The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index", "total i10 Productivity index", "last 6 years i10 Productivity index", "total citations" and "last 6 years citations" only in "AD Scientific Index". See also: Subject Rankings and University Subject Rankings. Click here for individual or institutional registration.
Only in AD Scientific Index !!!!
Subject Rankings, University Subject Rankings, Citiation Rankings, i10 Productivity Rankings, Country Rankings, Detailed analyses of universities
AD Scientific Index - World Scientists Rankings - 2024 | H INDEX | i10 INDEX | CITATION | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
University / Institution |
Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
101 | 168,039 | 189,309 | 604,680 |
|
United States | Eli Lilly and Company |
Others
|
16 | 10 | 0.625 | 19 | 10 | 0.526 | 1,424 | 532 | 0.374 |
102 | 170,314 | 191,797 | 613,729 |
|
United States | Eli Lilly and Company |
Others
|
15 | 15 | 1.000 | 18 | 16 | 0.889 | 1,123 | 696 | 0.620 |
103 | 171,098 | 192,621 | 616,021 |
|
United States | Eli Lilly and Company |
Others
Diabetic Side Complications | Signal Transduction | |
15 | 15 | 1.000 | 15 | 15 | 1.000 | 1,589 | 879 | 0.553 |
104 | 172,273 | 193,927 | 620,824 |
|
United States | Eli Lilly and Company |
Natural Sciences / Chemical Sciences
Computational Chemistry | Molecular Dynamics Simulation | Quantum Chemistry | Structure-Based Drug Design | |
15 | 14 | 0.933 | 18 | 16 | 0.889 | 877 | 665 | 0.758 |
105 | 172,603 | 194,290 | 621,801 |
|
United States | Eli Lilly and Company |
Others
Type 2 diabetes | non-alcoholic fatty liver disease | exercise training | metabolic flexibility | mitochondrial function | |
15 | 14 | 0.933 | 17 | 16 | 0.941 | 962 | 827 | 0.860 |
106 | 172,610 | 194,297 | 621,820 |
|
United States | Eli Lilly and Company |
Natural Sciences / Mathematical Sciences
Biostatistics | Clinical Trials | Data Science | |
15 | 14 | 0.933 | 17 | 17 | 1.000 | 939 | 889 | 0.947 |
107 | 172,752 | 194,451 | 622,274 |
|
United States | Eli Lilly and Company |
Others
|
15 | 14 | 0.933 | 16 | 16 | 1.000 | 3,386 | 2,091 | 0.618 |
108 | 172,936 | 194,642 | 622,632 |
|
United States | Eli Lilly and Company |
Natural Sciences / Chemical Sciences
Discovery Chemistry Research & Technology | |
15 | 14 | 0.933 | 16 | 15 | 0.938 | 1,207 | 636 | 0.527 |
109 | 173,973 | 195,782 | 627,329 |
|
United States | Eli Lilly and Company |
Engineering & Technology / Chemical Engineering
Chemical engineering | Particulate processes | Modeling and simulation | |
15 | 13 | 0.867 | 19 | 16 | 0.842 | 864 | 431 | 0.499 |
110 | 175,094 | 197,007 | 630,584 |
|
United States | Eli Lilly and Company |
Natural Sciences / Chemical Sciences
Catalysis | Medicinal Chemistry | |
15 | 13 | 0.867 | 15 | 14 | 0.933 | 1,910 | 1,169 | 0.612 |
Click for INSTITUTIONAL REGISTRATION and PREMIUM MEMBERSHIP advantages |
||||||||||||||||
111 | 176,349 | 198,427 | 636,609 |
|
United States | Eli Lilly and Company |
Others
|
15 | 12 | 0.800 | 17 | 14 | 0.824 | 773 | 463 | 0.599 |
112 | 176,359 | 198,438 | 636,638 |
|
United States | Eli Lilly and Company |
Medical and Health Sciences / Neuroscience
Neuroscience | Drug Discovery | Medical Affairs | Brain Neurochemistry | |
15 | 12 | 0.800 | 17 | 16 | 0.941 | 750 | 460 | 0.613 |
113 | 177,363 | 199,559 | 641,389 |
|
United States | Eli Lilly and Company |
Medical and Health Sciences / Pathology
Molecular Pathology | Translational Science | Clinical Diagnostics | |
15 | 11 | 0.733 | 18 | 13 | 0.722 | 2,604 | 1,980 | 0.760 |
114 | 177,823 | 200,058 | 642,789 |
|
United States | Eli Lilly and Company |
Others
|
15 | 11 | 0.733 | 16 | 11 | 0.688 | 1,603 | 528 | 0.329 |
115 | 179,413 | 201,832 | 650,274 |
|
United States | Eli Lilly and Company |
Others
|
15 | 9 | 0.600 | 17 | 9 | 0.529 | 1,341 | 771 | 0.575 |
116 | 183,382 | 206,172 | 665,876 |
|
United States | Eli Lilly and Company |
Others
|
14 | 13 | 0.929 | 17 | 14 | 0.824 | 1,499 | 567 | 0.378 |
117 | 183,432 | 206,225 | 666,033 |
|
United States | Eli Lilly and Company |
Others
Hepatocellular Carcinoma | Urothelial Carcinoma | Clinical Trial Design | Clinical Research | |
14 | 13 | 0.929 | 17 | 14 | 0.824 | 1,170 | 983 | 0.840 |
118 | 188,042 | 211,348 | 684,405 |
|
United States | Eli Lilly and Company |
Natural Sciences / Chemical Sciences
Process Chemistry | |
14 | 11 | 0.786 | 16 | 13 | 0.813 | 684 | 426 | 0.623 |
119 | 188,264 | 211,594 | 685,064 |
|
United States | Eli Lilly and Company |
Others
|
14 | 11 | 0.786 | 15 | 12 | 0.800 | 1,040 | 454 | 0.437 |
120 | 189,373 | 212,847 | 690,522 |
|
United States | Eli Lilly and Company |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Pharmacokinetics | Pharmacodynamics | Pharmacometrics | Modeling | Simulation | |
14 | 10 | 0.714 | 16 | 11 | 0.688 | 1,027 | 371 | 0.361 |
121 | 190,455 | 214,061 | 695,305 |
|
United States | Eli Lilly and Company |
Natural Sciences / Biological Science
biotechnology | diabetes | cancers | autoimmune diseases | |
14 | 9 | 0.643 | 16 | 9 | 0.563 | 1,171 | 249 | 0.213 |
122 | 194,128 | 218,112 | 710,062 |
|
United States | Eli Lilly and Company |
Medical and Health Sciences / Immunology
Immunology | |
13 | 13 | 1.000 | 13 | 13 | 1.000 | 4,017 | 1,362 | 0.339 |
123 | 196,956 | 221,223 | 720,160 |
|
United States | Eli Lilly and Company |
Natural Sciences / Molecular Biology & Genetics
Single-cell genomics | |
13 | 12 | 0.923 | 13 | 12 | 0.923 | 872 | 833 | 0.955 |
124 | 198,411 | 222,833 | 726,981 |
|
United States | Eli Lilly and Company |
Natural Sciences / Chemical Sciences
drug discovery and design | computational chemistry and ADME | |
13 | 11 | 0.846 | 14 | 13 | 0.929 | 1,206 | 1,102 | 0.914 |
125 | 198,541 | 222,974 | 727,370 |
|
United States | Eli Lilly and Company |
Others
|
13 | 11 | 0.846 | 14 | 12 | 0.857 | 851 | 539 | 0.633 |
126 | 199,046 | 223,526 | 728,789 |
|
United States | Eli Lilly and Company |
Others
Drug Design | Structural Bioinformatics | |
13 | 11 | 0.846 | 13 | 12 | 0.923 | 1,027 | 646 | 0.629 |
127 | 199,502 | 224,030 | 731,466 |
|
United States | Eli Lilly and Company |
Natural Sciences / Chemical Sciences
drug design | computational chemistry | |
13 | 10 | 0.769 | 17 | 12 | 0.706 | 969 | 448 | 0.462 |
128 | 202,292 | 227,187 | 744,268 |
|
United States | Eli Lilly and Company |
Natural Sciences / Chemical Sciences
Medicinal Chemistry | Synthetic Chemistry | |
13 | 8 | 0.615 | 17 | 5 | 0.294 | 889 | 149 | 0.168 |
129 | 202,882 | 227,831 | 746,881 |
|
United States | Eli Lilly and Company |
Natural Sciences / Molecular Biology & Genetics
Bioinformatics | Autoimmune diseases | Immunology | Transcriptional regulation | Genomics | |
13 | 8 | 0.615 | 13 | 8 | 0.615 | 2,168 | 774 | 0.357 |
130 | 203,460 | 228,462 | 749,428 |
|
United States | Eli Lilly and Company |
Business & Management / Business Administration
Clinical Biomarkers | apoptosis | cancer biology | neurodegeneration | flow cytometry | |
13 | 7 | 0.538 | 14 | 6 | 0.429 | 1,214 | 321 | 0.264 |
A New and Different Feature!!!! University Subject Rankings in 12 subjects:Ranking and analysis of universities by subject in 12 fields such as health, engineering, natural sciences, education, business, economics, social sciences, etc. |
||||||||||||||||
131 | 204,229 | 229,321 | 752,417 |
|
United States | Eli Lilly and Company |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Pharmaceuticals | Biotechnoloyg | |
13 | 3 | 0.231 | 15 | 2 | 0.133 | 4,918 | 1,874 | 0.381 |
132 | 204,458 | 229,574 | 753,907 |
|
United States | Eli Lilly and Company |
Others
Insulin Intervention | Hypoglycemia | Precision Medication | Survival Analysis | Recurrent Event Data Analysis | |
12 | 12 | 1.000 | 16 | 14 | 0.875 | 394 | 305 | 0.774 |
133 | 206,562 | 231,887 | 761,636 |
|
United States | Eli Lilly and Company |
Others
quantitative medical imaging | Cancer imaging | Neuroimaging | Radiomics | |
12 | 12 | 1.000 | 12 | 12 | 1.000 | 891 | 882 | 0.990 |
134 | 208,374 | 233,873 | 769,349 |
|
United States | Eli Lilly and Company |
Medical and Health Sciences / Neuroscience
Neuroscience | Magnetic Resonance Imaging | Magnetic Resonance Spectroscopy | MRI | MRS | |
12 | 11 | 0.917 | 13 | 12 | 0.923 | 883 | 411 | 0.465 |
135 | 209,700 | 235,341 | 774,001 |
|
United States | Eli Lilly and Company |
Others
|
12 | 10 | 0.833 | 19 | 11 | 0.579 | 749 | 497 | 0.664 |
136 | 209,772 | 235,428 | 774,779 |
|
United States | Eli Lilly and Company |
Others
|
12 | 10 | 0.833 | 17 | 14 | 0.824 | 374 | 311 | 0.832 |
137 | 209,955 | 235,636 | 775,850 |
|
United States | Eli Lilly and Company |
Natural Sciences / Chemical Sciences
Medicinal Chemistry | Drug Discovery | Oncology | Neuroscience | Data Science | |
12 | 10 | 0.833 | 15 | 10 | 0.667 | 839 | 314 | 0.374 |
138 | 213,109 | 239,144 | 789,314 |
|
United States | Eli Lilly and Company |
Others
GPCR | Structure- and ligand-based design | Molecular Dynamics | HTS hit analysis | Cheminformatics | |
12 | 9 | 0.750 | 13 | 9 | 0.692 | 482 | 275 | 0.571 |
139 | 213,508 | 239,588 | 790,585 |
|
United States | Eli Lilly and Company |
Medical and Health Sciences / Neuroscience
Neuroscience | Pharmacology | Gait Analysis | Behavior | Pain | |
12 | 9 | 0.750 | 12 | 9 | 0.750 | 642 | 339 | 0.528 |
140 | 214,713 | 240,910 | 796,394 |
|
United States | Eli Lilly and Company |
Natural Sciences / Biological Science
HDXMS Biophysics structural biology antibodies | |
12 | 8 | 0.667 | 12 | 8 | 0.667 | 956 | 710 | 0.743 |
Only in AD Scientific Index !!!!Subject Rankings, University Subject Rankings, Citiation Rankings, i10 Productivity Rankings, Country Rankings, Detailed analyses of universities |
||||||||||||||||
141 | 215,395 | 241,683 | 799,894 |
|
United States | Eli Lilly and Company |
Medical and Health Sciences / Neuroscience
Neuroscience | |
12 | 7 | 0.583 | 13 | 5 | 0.385 | 712 | 233 | 0.327 |
142 | 217,931 | 244,469 | 810,452 |
|
United States | Eli Lilly and Company |
Others
Alzheimer's Disease | Neurodegeneration | Neuroimaging | |
11 | 11 | 1.000 | 12 | 12 | 1.000 | 704 | 587 | 0.834 |
143 | 218,488 | 245,084 | 813,362 |
|
United States | Eli Lilly and Company |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Pharmacology | |
11 | 11 | 1.000 | 11 | 11 | 1.000 | 2,069 | 1,696 | 0.820 |
144 | 218,698 | 245,304 | 813,794 |
|
United States | Eli Lilly and Company |
Others
clinical trial | propensity score | causal inference | |
11 | 11 | 1.000 | 11 | 11 | 1.000 | 1,328 | 1,268 | 0.955 |
145 | 218,917 | 245,546 | 814,331 |
|
United States | Eli Lilly and Company |
Others
Randomized Controlled Trial | Subgroup Analysis | EM Application | |
11 | 11 | 1.000 | 11 | 11 | 1.000 | 978 | 885 | 0.905 |
146 | 220,063 | 246,816 | 819,876 |
|
United States | Eli Lilly and Company |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Pharmacokinetics | Pharmacodynamics | Pharmacometrics | |
11 | 10 | 0.909 | 13 | 10 | 0.769 | 750 | 394 | 0.525 |
147 | 221,441 | 248,347 | 825,877 |
|
United States | Eli Lilly and Company |
Natural Sciences / Chemical Sciences
Medicinal chemistry | oncology | organic synthesis | |
11 | 10 | 0.909 | 11 | 10 | 0.909 | 1,408 | 456 | 0.324 |
148 | 221,516 | 248,428 | 826,056 |
|
United States | Eli Lilly and Company |
Others
|
11 | 10 | 0.909 | 11 | 10 | 0.909 | 1,223 | 827 | 0.676 |
149 | 222,213 | 249,186 | 827,815 |
|
United States | Eli Lilly and Company |
Natural Sciences / Chemical Sciences
Mass Spectrometry | |
11 | 10 | 0.909 | 11 | 11 | 1.000 | 588 | 428 | 0.728 |
150 | 222,376 | 249,368 | 828,459 |
|
United States | Eli Lilly and Company |
Others
|
11 | 10 | 0.909 | 11 | 10 | 0.909 | 478 | 321 | 0.672 |